Radiomics in Alzheimer's Disease: seeking new imaging biomarkers to identify the early stages of the disease

Abstract

[EN] The valuable intrinsic information contained in many medical images has been under-exploited for too long. Now, new and rapidly developing technological advances for the acquisition of high-quality images and the processing of the underlying information in a rapid and intelligent way are allowing use of these ¿hidden¿ data, with the potential to revolutionize the field of radiology. The advances already achieved by this approach in oncology are sufficiently encouraging to justify its application to other difficult clinical challenges such as the diagnosis and staging of Alzheimer¿s disease (AD). This article summarizes the current status of radiomics analysis in AD and describes the potential of newly developed software for the identification of image texture biomarkers